Landmark Verdict: Natera Triumphs in Patent Battle Against CareDx’s Genetic Tests
In a dramatic legal showdown at the Delaware federal court, genetic-testing powerhouse Natera emerged victorious on Friday, persuading a jury that its competitor, CareDx, had infringed upon one of its patents with their kidney-transplant rejection tests, AlloSure and AlloSeq. The courtroom, normally bustling with legal battles, stood silent as the jury reached the decision, determining …
Landmark Verdict: Natera Triumphs in Patent Battle Against CareDx’s Genetic Tests Read More »


